BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

70 hedge funds and large institutions have $322M invested in Blueprint Medicines in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
1.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
6
Increased
30
Reduced
23
Closed
9
Calls
$11.4M
Puts
$43K
Net Calls
+$11.3M
Net Calls Change
-$8.09M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73.5M
2
PHS
2
PFM Health Sciences
California
$25.6M
3
BC
3
Boxer Capital
California
$12.7M
4
BI
4
BVF Inc
California
$47.7M
5
VAM
5
Visium Asset Management
New York
$22.8M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$1.02M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$2.29M
3
RG
3
Redmile Group
California
$488K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
CAM
5
Cormorant Asset Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAM
76
Panagora Asset Management
Massachusetts
– -$106K -4,015 Closed
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
– -$50.5K -1,916 Closed
Simplex Trading
78
Simplex Trading
Illinois
– -$27K -1,026 Closed
1 2 3
4